120 related articles for article (PubMed ID: 9874820)
1. Monte Carlo dose calculations for a new ovoid shield system for carcinoma of the uterine cervix.
Weeks KJ
Med Phys; 1998 Dec; 25(12):2288-92. PubMed ID: 9874820
[TBL] [Abstract][Full Text] [Related]
2. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging.
Price MJ; Jackson EF; Gifford KA; Eifel PJ; Mourtada F
Med Phys; 2009 Dec; 36(12):5515-24. PubMed ID: 20095264
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Monte Carlo calculations around a Fletcher Suit Delclos ovoid with radiochromic film and normoxic polymer gel dosimetry.
Gifford KA; Horton JL; Jackson EF; Steger TR; Heard MP; Mourtada F; Lawyer AA; Ibbott GS
Med Phys; 2005 Jul; 32(7):2288-94. PubMed ID: 16121584
[TBL] [Abstract][Full Text] [Related]
4. A monte carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shielded cylindrical applicator set.
Lymperopoulou G; Pantelis E; Papagiannis P; Rozaki-Mavrouli H; Sakelliou L; Baltas D; Karaiskos P
Med Phys; 2004 Nov; 31(11):3080-6. PubMed ID: 15587661
[TBL] [Abstract][Full Text] [Related]
5. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
Poon E; Williamson JF; Vuong T; Verhaegen F
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo model for a prototype CT-compatible, anatomically adaptive, shielded intracavitary brachytherapy applicator for the treatment of cervical cancer.
Price MJ; Gifford KA; Horton JL; Eifel PJ; Gillin MT; Lawyer AA; Mourtada F
Med Phys; 2009 Sep; 36(9):4147-55. PubMed ID: 19810488
[TBL] [Abstract][Full Text] [Related]
7. Screens in ovoids of a Selectron cervix applicator.
Meertens H; van der Laarse R
Radiother Oncol; 1985 Jan; 3(1):69-80. PubMed ID: 3975442
[TBL] [Abstract][Full Text] [Related]
8. [Rectal shielding for a Selectron-ring applicator system (HDR- and LDR-afterloading)].
Hetzel H; Kamleitner H; McCoy M; Frommhold H
Strahlenther Onkol; 1987 Dec; 163(12):782-6. PubMed ID: 3424077
[TBL] [Abstract][Full Text] [Related]
9. Using measured dose distribution data of the Fletcher-Suit-Delclos colpostat in brachytherapy treatment planning.
Yorke ED; Schell MC; Gaskill JW; Ling CC
Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1413-9. PubMed ID: 3624050
[TBL] [Abstract][Full Text] [Related]
10. Comparison of dose distributions around the pulsed-dose-rate Fletcher-Williamson and the low-dose-rate Fletcher-Suit-Delclos ovoids: a Monte Carlo study.
Price MJ; Gifford KA; Horton J; Lawyer A; Eifel P; Mourtada F
Phys Med Biol; 2006 Aug; 51(16):4083-94. PubMed ID: 16885626
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dose calculation algorithms for colorectal cancer brachytherapy treatment with a shielded applicator.
Yan X; Poon E; Reniers B; Vuong T; Verhaegen F
Med Phys; 2008 Nov; 35(11):4824-30. PubMed ID: 19070215
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional applicator system for carcinoma of the uterine cervix.
Weeks KJ; Montana GS
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):455-63. PubMed ID: 9069321
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo dosimetric characterization of the Cs-137 selectron/LDR source: evaluation of applicator attenuation and superposition approximation effects.
Pérez-Calatayud J; Granero D; Ballester F; Puchades V; Casal E
Med Phys; 2004 Mar; 31(3):493-9. PubMed ID: 15070245
[TBL] [Abstract][Full Text] [Related]
14. On the validity of the superposition principle in dose calculations for intracavitary implants with shielded vaginal colpostats.
Markman J; Williamson JF; Dempsey JF; Low DA
Med Phys; 2001 Feb; 28(2):147-55. PubMed ID: 11243337
[TBL] [Abstract][Full Text] [Related]
15. Experimental and Monte Carlo dosimetry of the Henschke applicator for high dose-rate 192Ir remote afterloading.
Watanabe Y; Roy J; Harrington PJ; Anderson LL
Med Phys; 1998 May; 25(5):736-45. PubMed ID: 9608485
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric characterization of model Cs-1 Rev2 cesium-131 brachytherapy source in water phantoms and human tissues with MCNP5 Monte Carlo simulation.
Wang J; Zhang H
Med Phys; 2008 Apr; 35(4):1571-9. PubMed ID: 18491551
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator.
Petrokokkinos L; Zourari K; Pantelis E; Moutsatsos A; Karaiskos P; Sakelliou L; Seimenis I; Georgiou E; Papagiannis P
Med Phys; 2011 Apr; 38(4):1981-92. PubMed ID: 21626931
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a 3-D multi-group SN particle transport code with Monte Carlo for intracavitary brachytherapy of the cervix uteri.
Gifford KA; Wareing TA; Failla G; Horton JL; Eifel PJ; Mourtada F
J Appl Clin Med Phys; 2009 Dec; 11(1):3103. PubMed ID: 20160682
[TBL] [Abstract][Full Text] [Related]
19. AAPM TG-43 formalism for brachytherapy dose calculation of a 137Cs tube source.
Zhang P; Beddar AS; Sibata CH
Med Phys; 2004 Apr; 31(4):755-9. PubMed ID: 15124992
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo calculations of dose rate distributions around the Amersham CDCS-M-type 137Cs source.
Casal E; Ballester F; Lluch JL; Pérez-Calatayud J; Lliso F
Med Phys; 2000 Jan; 27(1):132-40. PubMed ID: 10659748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
